Xtant Medical Holdings
XTNT
14 hedge funds and large institutions have $35.6M invested in Xtant Medical Holdings in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
8% more funds holding
Funds holding: 13 → 14 (+1)
0.2% more ownership
Funds ownership: 89.95% → 90.14% (+0.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $36.1M → $35.6M (-$542K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Telemetry Investments
New York
|
+$41.3K |
| 2 |
Renaissance Technologies
New York
|
+$23.1K |
| 3 |
BlackRock
New York
|
+$4.19K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$916 |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$46 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.4K |
| 2 |
Morgan Stanley
New York
|
-$2.03K |
XTNT Hedge Fund Activity: Q2 2019 in Review
14 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2019, worth a combined $35.6M — down 1.5% from $36.1M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new XTNT positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Telemetry Investments, adding an estimated $41.3K. The largest seller was Vanguard Group, cutting an estimated $15.4K.
- 14 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2019, up from 13 in Q1 2019.
- Funds reported $35.6M of Xtant Medical Holdings stock for Q2 2019, down 1.5% quarter-over-quarter.
- 1 fund opened new Xtant Medical Holdings positions in Q2 2019 and 0 closed out, a net change of +1 holder.
- The largest Xtant Medical Holdings buyer in Q2 2019 was Telemetry Investments, an estimated $41.3K added.
- The largest Xtant Medical Holdings seller in Q2 2019 was Vanguard Group, an estimated $15.4K sold.
Based on aggregated 13F filings for Q2 2019.